Colistimethate (Xellia Pharmaceuticals ApS)
Welcome to the PulseAid listing for the Colistimethate drug offered from Xellia Pharmaceuticals ApS. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Xellia Pharmaceuticals ApS |
| NON-PROPRIETARY NAME: | colistimethate sodium |
| SUBSTANCE NAME: | COLISTIMETHATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAMUSCULAR; INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2012-11-22 |
| END MARKETING DATE: | 0000-00-00 |
Colistimethate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Colistimethate from Xellia Pharmaceuticals ApS |
| LABELER NAME: | Xellia Pharmaceuticals ApS |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150(mg/2mL) |
| START MARKETING DATE: | 2012-11-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 45932-0023_ada0b3ec-6b19-49f0-858b-4c91032aef03 |
| PRODUCT NDC: | 45932-0023 |
| APPLICATION NUMBER: | ANDA205356 |
Other COLISTIMETHATE Pharmaceutical Manufacturers / Labelers:
